Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of share options

17 Oct 2017 09:10

RNS Number : 7995T
Touchstone Innovations PLC
17 October 2017
 

17 October 2017

 

Touchstone Innovations plc

 

Grant of share options

 

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation. 

 

Touchstone Innovations plc (AIM: IVO, "Innovations" or "the Group") has today granted options over ordinary shares in the capital of the Group ("Award Shares") to the following PDMRs under its 2016 Long Term Incentive Plan ("LTIP").

 

Number of Award Shares

Russ Cummings

315,515

Nigel Pitchford

94,827

Tony Hickson

55,173

Anjum Ahmad

46,433

 

The options have an exercise price of 3 1/33 (three and one thirty-third) pence per Award Share and are exercisable in three equal tranches during the six month periods commencing on 1 December 2020, 1 December 2021 and 1 December 2022 respectively, subject to certain performance conditions having been satisfied.

 

This grant of options is part of the Company's long-term incentive arrangements designed to align the interests of the shareholders and executives.

 

The LTIP was approved by shareholders of the Company at an annual general meeting on 21 November 2016 and was adopted by the Board on the same day. The LTIP provides for options to acquire ordinary shares to be granted to eligible employees. The arrangements are described more fully in the Directors' Remuneration Report in the Group's 2016 Annual Report, a copy of which is available on the Group's website (www.touchstoneinnovations.com).

 

For further information please contact:

 

Touchstone Innovations plc

020 3053 8834

David Newlands, Chairman

William Rayner, Company Secretary

 

Instinctif Partners

020 7457 2020

Adrian Duffield/Melanie Toyne-Sewell/Chantal Woolcock

 

J.P. Morgan Cazenove (Nominated Adviser)

020 7742 4000

Michael Wentworth-Stanley/Alec Pratt

 

RBC Capital Markets

020 7653 4000

Darrell Uden/Marcus Jackson/Laura White

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Russ Cummings

 

2.

Reason for the notification

a)

Position / status

CHIEF EXECUTIVE OFFICER

b)

Initial notification/amendment

INITIAL NOTIFICATION

3.

Details of issuer

a)

Name

touchstone Innovations plc

b)

LEI

213800D4RUIF3HLITE31

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

NOMINAL VALUE OPTIONS OVER ORDINARY SHARES OF 3 1/33 PENCE EACH IN THE CAPITAL OF THE COMPANY

GB00B170L953

b)

Nature of the transaction

grant of long term incentive plan awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

315,515

d)

Aggregated information

 

Aggregated volume price

N/A

 

e)

Date of the transaction

 

2017-10-17

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

nigel pitchford

2.

Reason for the notification

a)

Position / status

CHIEF INVESTMENT OFFICER

b)

Initial notification/amendment

INITIAL NOTIFICATION

3.

Details of issuer

a)

Name

touchstone Innovations plc

b)

LEI

213800D4RUIF3HLITE31

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

NOMINAL VALUE OPTIONS OVER ORDINARY SHARES OF 3 1/33 PENCE EACH IN THE CAPITAL OF THE COMPANY

GB00B170L953

b)

Nature of the transaction

grant of long term incentive plan awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

94,827

d)

Aggregated information

 

Aggregated volume price

N/A

 

e)

Date of the transaction

 

2017-10-17

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

TONY HICKSON

 

2.

Reason for the notification

a)

Position / status

MANAGING DIRECTOR - TECHNOLOGY TRANSFER

b)

Initial notification/amendment

INITIAL NOTIFICATION

3.

Details of issuer

a)

Name

touchstone Innovations plc

b)

LEI

213800D4RUIF3HLITE31

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

NOMINAL VALUE OPTIONS OVER ORDINARY SHARES OF 3 1/33 PENCE EACH IN THE CAPITAL OF THE COMPANY

GB00B170L953

b)

Nature of the transaction

grant of long term incentive plan awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

55,173

d)

Aggregated information

 

Aggregated volume price

N/A

 

e)

Date of the transaction

 

2017-10-17

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

ANJUM AHMAD

 

2.

Reason for the notification

a)

Position / status

TREASURY AND FINANCE DIRECTOR

b)

Initial notification/amendment

INITIAL NOTIFICATION

3.

Details of issuer

a)

Name

touchstone Innovations plc

b)

LEI

213800D4RUIF3HLITE31

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

NOMINAL VALUE OPTIONS OVER ORDINARY SHARES OF 3 1/33 PENCE EACH IN THE CAPITAL OF THE COMPANY

GB00B170L953

b)

Nature of the transaction

grant of long term incentive plan awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

46,433

d)

Aggregated information

 

Aggregated volume price

N/A

 

e)

Date of the transaction

 

2017-10-17

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAPEXFENXFEF
Date   Source Headline
5th Sep 20162:40 pmRNSHolding(s) in Company
24th Aug 20167:01 amRNSCell Medica and UCL collaboration
12th Jul 20167:02 amRNSCell Medica acquires Delenex Therapeutics
6th Jul 20167:00 amRNSEconic raises £5m to develop novel catalyst tech
30th Jun 201612:11 pmRNSPsiOxus and Bristol-Myers Squibb collaboration
28th Jun 20167:00 amRNSStorm Therapeutics raises £12m
21st Jun 20164:35 pmRNSPrice Monitoring Extension
21st Jun 20167:00 amRNSDirector's share purchase
20th Jun 20167:03 amRNSCircassia cat allergy Phase III study
17th Jun 20167:00 amRNSCell Medica and Baylor College of Medicine partner
16th Jun 201610:44 amRNSReplacement Holding(s) in Company
14th Jun 20163:20 pmRNSEdison issues outlook on Imperial Innovations)
14th Jun 20169:00 amRNSHolding(s) in Company
13th Jun 20167:00 amRNSAllotment of Deferred Placing Shares
31st May 20167:00 amRNSFeaturespace closes £6.2 million funding round
26th May 20167:00 amRNS£3 million funding round for Inflowmatix
11th May 201612:32 pmRNSDavid Newlands appointed Chairman
4th May 20164:35 pmRNSPrice Monitoring Extension
4th May 201611:08 amRNSNexeon raises £30m, plans development lab in Asia
4th May 20167:00 amRNSAnalyst and Investor day
29th Apr 20164:35 pmRNSPrice Monitoring Extension
29th Apr 201612:42 pmRNSSale of Innovations portfolio Stanmore Implants
7th Apr 20167:00 amRNSHalf Yearly Report
21st Mar 20167:00 amRNSDr Martin Knight to step down from the board
18th Mar 201612:40 pmRNSNotice of Results
17th Mar 20167:00 amRNSTopiVert reports successful Phase I clinical study
26th Feb 20168:39 amRNSHolding(s) in Company
25th Feb 20163:59 pmRNSHolding(s) in Company
25th Feb 20163:50 pmRNSHolding(s) in Company
25th Feb 20168:53 amRNSHolding(s) in Company
22nd Feb 20165:01 pmRNSAdmission of shares to trading on AIM
22nd Feb 201612:29 pmRNSResult of General Meeting
22nd Feb 20167:00 amRNS£13.5m funding round in Precision Ocular
11th Feb 20162:51 pmRNSHolding(s) in Company
8th Feb 20167:00 amRNSInnovations leads £5m Series A round in Aqdot
4th Feb 20166:08 pmRNSResult of Placing
4th Feb 20167:00 amRNSPlacing to raise £100 million
2nd Feb 20167:00 amRNSMISSION Therapeutics raises £60 million
26th Jan 20167:00 amRNSInivata completes £31.5m Series A funding round
25th Jan 20167:00 amRNSInnovations joins Apollo consortium
18th Jan 20167:00 amRNSInnovations invests £25m in new £50m UCL Tech Fund
2nd Dec 20157:00 amRNSKesios Therapeutics raises £19 million
19th Nov 20151:51 pmRNSResult of AGM
4th Nov 20151:40 pmRNSGrant of share options
28th Oct 20157:00 amRNSPosting of Annual Report and Notice of AGM
22nd Oct 20157:00 amRNSLeads £1.5m seed funding into AI pioneer, Telectic
14th Oct 20157:00 amRNSFinal Results
22nd Sep 20154:10 pmRNSNotice of Results
12th Aug 20157:00 amRNSIssue of Equity
4th Aug 20157:01 amRNS£2.5m funding round in Oxford Biotrans

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.